about
Target Definition in Salvage Radiotherapy for Recurrent Prostate Cancer: The Role of Advanced Molecular ImagingClinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework.Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework.Approaches for the optimization of MR protocols in clinical hybrid PET/MRI studies.PET evidence of central GABAergic changes in stiff-person syndrome.Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical settingAssociation of adenosine receptor gene polymorphisms and in vivo adenosine A1 receptor binding in the human brain.Qualitative and Quantitative Evaluation of Blob-Based Time-of-Flight PET Image Reconstruction in Hybrid Brain PET/MR Imaging.Discriminating among degenerative parkinsonisms using advanced (123)I-ioflupane SPECT analyses.Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson's disease.PET radiotracers for molecular imaging in dementia.Gender differences in healthy aging and Alzheimer's Dementia: A 18 F-FDG-PET study of brain and cognitive reserve.FDG PET/MR Imaging in Major Neurocognitive Disorders.Scan without evidence of dopaminergic deficit: A 10-year retrospective study.Preliminary evidence of validity of the revised criteria for Alzheimer disease diagnosis: report of 2 cases.Distinct spatiotemporal patterns for disease duration and stage in Parkinson's disease.Significance of 18F-fluorocholine PET/CT positive pulmonary lesions in prostate cancer patients.All-in-one interictal presurgical imaging in patients with epilepsy: single-session EEG/PET/(f)MRI.Whole-Body SPECT/CT versus Planar Bone Scan with Targeted SPECT/CT for Metastatic WorkupEstablishing On-Site Reference Values for (123)I-FP-CIT SPECT (DaTSCAN®) Using a Cohort of Individuals with Non-Degenerative Conditions.Hybrid PET/MRI as a tool to detect brown adipose tissue: Proof of principle.Yield of MRI, high-density electric source imaging (HD-ESI), SPECT and PET in epilepsy surgery candidates.Persistent autobiographical amnesia: a case reportGlucose metabolism and dopamine PET correlates in a patient with myotonic dystrophy type 2 and parkinsonism.Revisiting brain reserve hypothesis in frontotemporal dementia: evidence from a brain perfusion study.White matter changes in corticobasal degeneration syndrome and correlation with limb apraxia.Localization of the epileptogenic tuber with electric source imaging in patients with tuberous sclerosis.The need of standardization and of large clinical studies in an emerging indication of [18F]FDG PET: the autoimmune encephalitis.Education and occupation as proxies for reserve in aMCI converters and AD: FDG-PET evidence.Erratum to: The need of standardization and of large clinical studies in an emerging indication of [18 F]FDG PET: the autoimmune encephalitis.In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder.Positron emission tomography changes in PARK1 mutation.123I-FP-CIT SPECT Accurately Distinguishes Parkinsonian From Cerebellar Variant of Multiple System Atrophy.Clinical utility of 18F-FDG-PET/MR for preoperative breast cancer staging.A Cochrane review on brain [¹⁸F]FDG PET in dementia: limitations and future perspectives.Teaching NeuroImages: Drug-induced parkinsonism with asymmetrical putaminal DaT binding.Tracking the source of cerebellar epilepsy: hemifacial seizures associated with cerebellar cortical dysplasia.Clinical applications of hybrid PET/MRI in neuroimaging.Dopaminergic denervation is not necessary to induce gait disorders in atypical parkinsonian syndrome.Source-Based Morphometry Multivariate Approach to Analyze [123I]FP-CIT SPECT Imaging.
P50
Q28074669-82CFC18A-FCA8-48F5-BB3E-4CDF99F4FD06Q30235197-672CB241-3856-416F-A7F4-4359EEFE5900Q30235199-6206708B-9542-4862-ACCC-51DB312B81CBQ30570489-89C4B882-DC2E-4526-B535-24E5BEB669FFQ33288028-06878F1C-1670-49E9-8A84-55AD0AE08736Q34477727-BD71767F-710B-42B6-BE93-9CB3A1F89C0FQ34499277-1429F6F4-C1A3-4145-9FA2-51ACD69C6B13Q36621621-74887F4E-B5C5-46F1-A267-22D9A7A88BBCQ37107811-DD645D70-BF65-410D-81B3-D3E8F474327FQ37737032-911AADEA-0532-4890-B73A-6F0F50E6CF82Q38166855-1729121A-205C-41F2-A283-C8FD04564F5AQ38754589-CFD10932-9BC0-4425-A222-D604AF642E88Q38849519-BD820DBE-7F0E-4B8A-ACDC-8AA6A4C678B4Q39193378-15274317-1403-4869-B5FE-9C03499FAFB9Q39966471-27545470-8B5B-465E-87E8-5D7BBAC99769Q40595268-636F50DF-6B32-4A81-ACB6-637C1A4210D1Q40693933-4FD6701B-6351-4550-833B-C5A8F888E2E8Q41040738-BCC664F3-E3F0-4EE9-831C-C653DF8F5005Q41275961-86056ED7-2DA2-4708-B91C-74875AB75DDBQ41409967-4AB47A71-F0C3-49C4-BC9C-15C86296C896Q41687618-DF894C7A-2FA7-4FD2-818C-F39CB2E3E6E1Q41710962-41B5C6AE-A796-4CC0-BF8C-372C22015757Q41769233-352F27F5-BCB4-4C50-9631-0E246F2E18D9Q42718645-C7A3A10A-6147-4699-AAD2-4CF09403EBAAQ43289972-92A5B8F0-0DBD-4221-854E-769BB161069FQ44061334-583D667D-5BE7-484F-AA4F-8EA652D98B24Q44148481-0DBBF934-8A13-4AF9-A6B6-865F11A5F823Q46106323-B57153A1-835A-49B5-8056-8CFC4AC3565CQ46116889-2EA1469E-7A33-44A2-AE83-A8C511D1975AQ46327044-5295DA3B-4EA8-48A5-8FAD-2AD51C0DD663Q46568434-14BFDE9B-CD44-44DD-AF24-35896E1D4231Q46741138-CA4329FC-287A-4C0A-8CAD-774D30F889B9Q47568133-9D2111A7-FB1C-4138-AF26-49D2F9B65A35Q48118323-3342C3A0-6EA5-4707-9F8C-F238D7C84F7AQ48132965-96574D2F-BB0A-4CB1-B0B0-E598BD7575A6Q48170536-86C97583-DE32-4B88-82B7-E411AB7FF56CQ48179913-439FFE86-AE80-4398-B2F2-D219185A7875Q48252710-0FAD4C77-6166-4EE9-872C-8A2E04F647CAQ48280406-AEF4EFAA-E55D-4637-B306-3A4A31433EB2Q48310376-48358E9B-E0B5-4977-99AE-7259A7659A4E
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-2422-698X
@en
name
Valentina Garibotto
@ast
Valentina Garibotto
@en
Valentina Garibotto
@es
Valentina Garibotto
@nl
type
label
Valentina Garibotto
@ast
Valentina Garibotto
@en
Valentina Garibotto
@es
Valentina Garibotto
@nl
prefLabel
Valentina Garibotto
@ast
Valentina Garibotto
@en
Valentina Garibotto
@es
Valentina Garibotto
@nl
P106
P31
P496
0000-0003-2422-698X